Compare Wegovy vs Mounjaro UK - Both Available Now
Wegovy or Mounjaro UK Stock Availability - No More Waiting
The frustration of finding Wegovy or Mounjaro UK in stock has been a genuine concern for patients seeking reliable weight management support. Unlike other suppliers who have faced significant stock shortages, EverydayMeds maintains consistent inventory across all dose strengths for both treatments. Our direct supply relationship with Novo Nordisk ensures Wegovy availability from the 0.25mg starter dose through to the 2.4mg maintenance pen, while our Mounjaro stock covers the complete tirzepatide range.
This reliable availability means you can begin treatment immediately after clinical approval, without the anxiety of supply interruptions during your dose escalation phase. Both Wegovy or Mounjaro UK treatments require careful dose progression over 16-20 weeks, making consistent stock availability essential for treatment success. Our pharmacy management system automatically monitors stock levels and triggers reorders before any potential shortages, ensuring patients never face treatment delays.
Wegovy or Mounjaro UK Pricing - Complete Cost Breakdown
Understanding the investment required for Wegovy or Mounjaro UK helps you plan your weight management journey effectively. Wegovy single pens start at £79.99 for the 0.25mg starter dose after applying discount code FIRST40, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenient dose progression, with the Intro Duo (0.25mg and 0.5mg) priced at £169.99 for your first 8 weeks of treatment.
For patients requiring extended supply security, our Take-It-Slow bundles offer multiple pens of the same strength, such as the Gentle Start Trio providing three 0.25mg pens for £269.99. Returning customers benefit from the DOSE25 discount code, while new patients use FIRST40 - both applied at checkout to reach these final prices. This transparent pricing structure eliminates any surprises and allows you to budget effectively for your chosen treatment, whether Wegovy or Mounjaro UK.
Clinical Evidence for Wegovy or Mounjaro UK Effectiveness
Both Wegovy or Mounjaro UK treatments have demonstrated significant efficacy in clinical trials, though direct comparisons should be interpreted carefully due to different study designs. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks (Wilding et al., NEJM, 2021), with some studies showing sustained results over 2 years. The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events among patients with established cardiovascular disease.
Mounjaro's SURMOUNT clinical programme has shown promising results with tirzepatide's dual GIP and GLP-1 receptor agonism approach, though these trials used different patient populations and endpoints. Both prescription-only medicines represent evidence-based approaches to weight management when used appropriately under medical supervision. Your prescriber can help determine which clinical profile aligns best with your individual health circumstances and treatment goals.
How Wegovy Works - GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a naturally occurring fullness hormone in your body. This mechanism works primarily on appetite centres in the brain, helping reduce food cravings and promoting earlier feelings of fullness during meals. The treatment may help slow gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Unlike stimulant-based weight management approaches, Wegovy's GLP-1 action works with your body's existing hunger and satiety signals rather than artificially suppressing them. This natural hormone-mimicking approach explains why patients often report more manageable portion sizes and reduced food preoccupation during treatment.
Ordering Process for Wegovy or Mounjaro UK
Accessing Wegovy or Mounjaro UK through EverydayMeds begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within standard 3 working days, or within 24 hours if you select express review during checkout. Once approved, your prescription-only medicine is prepared in our temperature-controlled facility and dispatched via next-day delivery using specialist cold-chain packaging. You'll receive tracking information and delivery instructions to ensure your treatment maintains the required 2-8°C storage temperature throughout transit. This streamlined process eliminates the traditional barriers of GP appointments and pharmacy visits while maintaining full clinical oversight.
Storage and Practical Considerations for Wegovy or Mounjaro UK
Both Wegovy or Mounjaro UK treatments require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability versus Mounjaro's 21-day limit. The weekly injection schedule uses pre-filled FlexTouch pens with hidden needles, making administration straightforward for injection-anxious patients. Dose escalation follows a mandatory schedule over 16 weeks, starting with 0.25mg weekly and gradually increasing to the 2.4mg maintenance dose - this cannot be rushed or modified without medical supervision. Both treatments should be administered on the same day each week, with flexibility to adjust timing by plus or minus 3 days if needed. Proper injection site rotation between abdomen, thigh, and upper arm areas helps minimise potential injection site reactions.
Wegovy or Mounjaro UK - Making the Right Choice for Your Situation
The decision between Wegovy or Mounjaro UK often comes down to individual factors including your response to previous treatments, medical history, and practical considerations like travel requirements. Wegovy's established clinical profile and longer room-temperature stability make it suitable for patients with frequent travel or variable schedules. The semaglutide in Wegovy shares the same active ingredient family as diabetes medications, providing additional cardiovascular benefits demonstrated in the SELECT trial.
Mounjaro's dual-hormone approach may appeal to patients seeking the newest treatment innovation, though both options require the same commitment to dietary changes and increased physical activity. Your prescriber will consider factors like your diabetes status, cardiovascular risk profile, and previous medication responses when recommending between these treatments. Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you can access whichever option your prescriber determines most appropriate.
Secure Your Wegovy or Mounjaro UK Supply Today
With both Wegovy or Mounjaro UK available for immediate dispatch, there's no need to delay starting your medically-supervised weight management journey. New customers can apply discount code FIRST40 at checkout, while returning patients use DOSE25 to access our competitive pricing structure. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and secure your prescription-only medicine supply from our GPhC-registered pharmacy. Our clinical team reviews every application thoroughly, ensuring safe and appropriate prescribing while maintaining the fastest possible approval times. Don't let supply concerns delay your health goals when both proven treatments are available now through our reliable service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
